Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕Aditya Birla Sun Life Manufacturing Equity Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundAditya Birla Sun Life Manufacturing Equity Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaABSL
NAV₹666.3420₹43.4400
NAV date20 Nov 202620 Nov 2026
History13.9 years11.8 years
Expense ratio1.0%1.4%
Stars★★★★★★★★★★
Growth Score75.2061.20

Returns

Nippon India Pharma FundAditya Birla Sun Life Manufacturing Equity Fund
1 month+11.40%+4.32%
3 months+3.74%−3.23%
6 months+8.55%+9.67%
YTD+16.94%+17.72%
1 year+15.26%+17.41%
3 years (CAGR)+17.96%+20.17%
5 years (CAGR)+15.40%+15.48%
10 years (CAGR)+16.61%+14.89%
Since launch+17.63%+13.25%

Risk

Nippon India Pharma FundAditya Birla Sun Life Manufacturing Equity Fund
Volatility14.1%18.3%
Downside volatility9.0%11.1%
Sharpe0.810.75
Sortino1.281.23
Calmar1.220.88
Return / risk1.271.11
Deepest fall−24.02%−39.19%
Days to recover445254
Below its high+0.00%−4.21%

Against benchmark

Nippon India Pharma FundAditya Birla Sun Life Manufacturing Equity Fund
Alpha−1.86%+7.73%
Beta0.891.00
R²89.5%78.2%
Up capture85.2%127.7%
Down capture88.7%98.5%
Tracking error4.8%8.5%
Information ratio−0.690.91
Treynor0.120.13

Consistency

Nippon India Pharma FundAditya Birla Sun Life Manufacturing Equity Fund
Best 1-year+90.70%+82.22%
Middle 1-year+13.13%+13.72%
Worst 1-year−15.12%−26.73%
1-year periods with a loss23.2%26.2%
Middle 3-year+19.82%+15.60%
Positive months63.9%63.9%
Best day+3.40%+3.56%
Worst day−3.21%−6.36%
Worst 5% day−1.38%−1.69%
Positive days53.7%56.5%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundAditya Birla Sun Life Manufacturing Equity Fund
5-year XIRR+18.24%+18.14%
5-year value₹9,54,076₹9,51,700
3-year XIRR+14.26%+15.66%
1-year XIRR+22.08%+20.03%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth